Original Article

The Evaluation of Effectiveness of New Endogenous Biomarkers for Renal Functions in Type 2 Diabetic Patients
  • Savaş Öztürk
  • Fuat Şar
  • Fatma Aksak
  • Zuhal Sağlam
  • Mustafa Yenigün
  • Filiz B. Cömert
  • Macit Koldaş
  • Rümeyza Kazancıoğu
Med Bull Haseki 2008; 46: 57-62
The Diagnostic Rate and Clinical Implications of Neuron-Specific Enolase in Neuroendocrine Tumors and Small Cell Lung Cancer: Data from the Ministry of Health of the Republic of Turkey
  • Suayip Birinci
  • Mustafa Mahir Ulgu
Med Bull Haseki 2023; 61: 231-237 DOI: 10.4274/haseki.galenos.2023.9375
Are Uric Acid Level and Uric Acid/Creatinine Ratio Reliable Biomarkers for Idiopathic Parkinson’s Disease Severity?
  • Vasfiye Burcu Albay
  • Mesude Tütüncü
Med Bull Haseki 2020; 58: 315-319 DOI: 10.4274/haseki.galenos.2020.5903
Can We Use Inflammation Biomarkers Based on Complete Blood Cell Count in the Follow-up of COVID-19 in Hemodialysis Patients?
  • Kubra Aydin Bahat
  • Tugba Tahtali
Med Bull Haseki 2022; 60: 345-350 DOI: 10.4274/haseki.galenos.2022.8694
Diagnostic Value of Novel Presepsin and Inflammatory Biomarkers in Predicting the Clinical Course of COVID-19
  • Faraz Hasan Mirza
  • Faraz Ahmed Baig
  • Serajuddaula Syed
Med Bull Haseki 2021; 59: 358-362 DOI: 10.4274/haseki.galenos.2021.7653